Is Illumina Still the Gamechanger in Genomics Sequencing? Genome sequencing solutions company Illumina (NASDAQ: ILMN) stock has fallen under its pandemic lows. A surprise earnings miss, and lowered guidance has caused Previous Article Here’s What Makes Amazon a Sum-of-All-Parts Commerce Juggernaut Next Article 20 Unsafe Foods That Contain Petroleum and Toxins